Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01700 |
| Species: | Homo sapiens |
| Position : | chr6:31130000-31131000 |
| Year: | 2022 |
| Title: | Comparison of dCas9-based transcriptional activators at human enhancer-promoter pairs |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cervical cancer |
| PMID: | 35849129 |
| MONDO: | MONDO:0001156 |
| Tissue: | Cervix |
| Tissue Ontology ID: | UBERON:0000002 |
| Cell Source: | HeLa |
| CVCL ID: | CVCL_0030 |
| Cell Type: | cervical adenocarcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | |
| Low Throughput Method: | CRISPR Knockout, CRISPRi, RT-RT-qPCR |
| Target gene : | POU5F1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|